AU2003262277A1 - Inhibitor of proliferation and/or infiltration of tumor cells - Google Patents

Inhibitor of proliferation and/or infiltration of tumor cells

Info

Publication number
AU2003262277A1
AU2003262277A1 AU2003262277A AU2003262277A AU2003262277A1 AU 2003262277 A1 AU2003262277 A1 AU 2003262277A1 AU 2003262277 A AU2003262277 A AU 2003262277A AU 2003262277 A AU2003262277 A AU 2003262277A AU 2003262277 A1 AU2003262277 A1 AU 2003262277A1
Authority
AU
Australia
Prior art keywords
infiltration
proliferation
inhibitor
tumor cells
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003262277A
Inventor
You Aso
Kimi Honma
Takahiro Ochiya
Masaaki Terada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koken Co Ltd
Original Assignee
Koken Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koken Co Ltd filed Critical Koken Co Ltd
Publication of AU2003262277A1 publication Critical patent/AU2003262277A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2003262277A 2002-12-03 2003-08-22 Inhibitor of proliferation and/or infiltration of tumor cells Abandoned AU2003262277A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002351599 2002-12-03
JP2002/351599 2002-12-03
PCT/JP2003/010631 WO2004050125A1 (en) 2002-12-03 2003-08-22 Inhibitor of proliferation and/or infiltration of tumor cells

Publications (1)

Publication Number Publication Date
AU2003262277A1 true AU2003262277A1 (en) 2004-06-23

Family

ID=32463159

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003262277A Abandoned AU2003262277A1 (en) 2002-12-03 2003-08-22 Inhibitor of proliferation and/or infiltration of tumor cells

Country Status (3)

Country Link
JP (1) JPWO2004050125A1 (en)
AU (1) AU2003262277A1 (en)
WO (1) WO2004050125A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2290067B1 (en) 2004-05-28 2014-12-10 Asuragen, Inc. Methods and compositions involving microRNA
ES2534302T3 (en) 2004-11-12 2015-04-21 Asuragen, Inc. Procedures and compositions involving miRNA and miRNA inhibitor molecules
US8361714B2 (en) 2007-09-14 2013-01-29 Asuragen, Inc. Micrornas differentially expressed in cervical cancer and uses thereof
US8258111B2 (en) 2008-05-08 2012-09-04 The Johns Hopkins University Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
WO2013040251A2 (en) 2011-09-13 2013-03-21 Asurgen, Inc. Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615710A1 (en) * 1996-04-22 1997-10-23 Forssmann Wolf Georg Process for obtaining and using a biologically active protein - collagen fragment HF-COLL-18 / 514cf - in partially purified and synthetic form from body fluids to influence cell growth and the diagnosis of collagen diseases and osteoporosis
CA2318432C (en) * 1998-03-27 2003-01-28 University Of Kansas Medical Center The use of isolated domains of type iv collagen to modify cell and tissue interactions
JP2002539174A (en) * 1999-03-17 2002-11-19 エントレメッド インコーポレイテッド Compositions and methods using LDL-like receptor ligands for the treatment of cancer and angiogenesis-related diseases
JP4487277B2 (en) * 2000-08-30 2010-06-23 司甫 横山 Foods and beverages and pharmaceuticals such as health foods

Also Published As

Publication number Publication date
JPWO2004050125A1 (en) 2006-03-30
WO2004050125A1 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
AU2003275311A1 (en) Solid micro-perforators and methods of use
AU2003299509A1 (en) Crosslinked compounds and methods of making and using thereof
AU2003299734A1 (en) Luminescent polymers and methods of use thereof
AU2003217870A1 (en) Pini-modulating compounds and methods of use thereof
AU2003225668A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003225669A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003213673A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003296176A1 (en) Inhibitor for liver cancer onset and progress
EP1539248A4 (en) INHIBITORS OF THE S100-p53 PROTEIN-PROTEIN INTERACTION AND METHOD OF INHIBITING CANCER EMPLOYING THE SAME
AU2003259677A1 (en) Rotatable assemblies and methods of securing such assemblies
AU2003220437A1 (en) Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
AU2002341749A1 (en) Methods and compositions for inhibiting the proliferation of prostate cancer cells
AU2003277871A1 (en) New compounds for the inhibition of undesired cell proliferation and use thereof
AU2003210983A1 (en) Kinase inhibitors and methods of use thereof
AU2003275065A8 (en) Molecular targets of cancer and aging
AU2003215244A1 (en) Complexes and methods of using same
AU2003262277A1 (en) Inhibitor of proliferation and/or infiltration of tumor cells
AU2003251513A1 (en) Rsk inhibitors and therapeutic uses thereof
AU2003245627A1 (en) Kinases and phosphatases
AU2003226496A1 (en) Pharmaceutical combination of the cox-2 inhibitor etodolac and opioids
AU2003287802A1 (en) Palpometer and methods of use thereof
AU2003254064A1 (en) Amplification and overexpression of oncogenes
AU2003285686A1 (en) Glycoisoforms of adiponectin and uses thereof
AU2003216810A1 (en) Combination ofa cdk inhibitor and 5-fu for the treatment of cancer
AU2003231803A1 (en) Treatment of cancer with mefloquire

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase